在COVID-19患者的炎症标志物和淋巴细胞子集与呼吸道细菌共感染:临床影响

Tongtong Guo1, Baolin Li1, Haojun Huang1

  • 1Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Sichuan, PR China.

概括

早期识别COVID-19患者的细菌共同感染至关重要. 炎症标志物和淋巴细胞子集在检测这些常见的二次感染方面表现有前途.